XML 61 R28.htm IDEA: XBRL DOCUMENT v3.25.0.1

Net Income Per Share (Tables)

12 Months Ended

Dec. 31, 2024

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net income per share

The following table shows the computation of basic and diluted net income per share for the years ended December 31, 2024, 2023 and 2022:

		Year Ended December 31,
(In thousands except per share data)		2024				2023				2022
Numerator:
Net income attributable to Innoviva stockholders, basic		$	23,392			$	179,722			$	213,921
Add: interest expense on 2023 Notes, net of tax effect			—				89				2,439
Add: interest expense on 2025 Notes, net of tax effect			3,468				5,116				4,583
Add: interest expense on 2028 Notes, net of tax effect			—				6,377				4,626
Net income attributable to Innoviva stockholders, diluted		$	26,860			$	191,304			$	225,569
Denominator:
Weighted-average shares used to compute basic net income    per share attributable to Innoviva stockholders			62,726				65,435				69,644
Dilutive effect of 2023 Notes			—				187				6,188
Dilutive effect of 2025 Notes			11,150				11,150				11,150
Dilutive effect of 2028 Notes			—				9,955				8,158
Dilutive effect of options and awards granted under equity    incentive plan and employee stock purchase plan			311				149				108
Weighted-average shares used to compute diluted net income    per share attributable to Innoviva stockholders			74,187				86,876				95,248
Net income per share attributable to Innoviva stockholders
Basic		$	0.37			$	2.75			$	3.07
Diluted		$	0.36			$	2.20			$	2.37

Schedule of anti-dilutive securities

The following common stock equivalents were not included in the computation of diluted net income per share because their effect was anti‑dilutive for the periods presented:

		Year Ended December 31,
(In thousands)		2024				2023				2022
Outstanding options and awards granted under equity incentive    plan and employee stock purchase plan			1,196				1,333				648
Outstanding stock warrant			591				591				282
Outstanding 2028 Notes			9,955				—				—
Total			11,742				1,924				930

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration